News in Numbers
Eli Lilly reported a net income of $1.76bn in Q2 2023, which is an increase of 85% compared to the same period last year.
As per the Centers for Disease Control and Prevention, at least 1.7 million adults in the US develop sepsis each year.
Thermo Fisher completed the acquisition of data intelligence company CorEvitas for $912.5m in cash, in August.
CVS Health announced plans to launch a biosimilar of AbbVie’s Humira (adalimumab) through its subsidiary Corvadis, in Q1 2024, which will be 80% cheaper than Humira.
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has awarded a positive opinion on 46 new medicines in 2023, as of July.